![](/img/cover-not-exists.png)
A 6-month, randomized, double-blind, placebo-controlled pilot discontinuation trial following response to haloperidol treatment of psychosis and agitation in Alzheimer's disease
D.P. Devanand, Gregory H. Pelton, Karine Cunqueiro, Harold A. Sackeim, Karen MarderVolume:
26
Year:
2011
Language:
english
Pages:
7
DOI:
10.1002/gps.2630
File:
PDF, 215 KB
english, 2011